Literature DB >> 8683506

Characteristics of referrals to an inpatient hospice and a survey of general practitioner perceptions of palliative care.

D A Seamark1, C Lawrence, J Gilbert.   

Abstract

In order to determine symptoms, drug prescribing and physical problems of patients referred to an inpatient hospice, case notes from 130 consecutive first admissions (95 general practitioner (GP) referrals, 35 consultant referrals) were analysed. GP referrals were more likely to be constipated, require care and be discharged to home. Consultant referrals were more gravely ill, dependent and more likely to die in the hospice. On admission 76 (58%) patients were receiving opiates with co-prescription of opiate and laxative occurring in 41% (31/76) of the cases. The prescription of laxatives with the symptoms of constipation occurred in 62% (26/42) of the cases on admission. A telephone survey of 79 referring GPs revealed that 37% had attended neither a course nor a lecture relevant to palliative care in the past 3 years. GPs experienced difficulties frequently or always in: (a) managing pain (8/79); (b) managing other symptoms (25/79); (c) helping patients and relatives cope with their emotional distress (18/79); and (d) coping with their own emotional responses to death and dying (5/79). In conclusion, the differences demonstrated between the GP and consultant referrals have implications for purchasers. The high incidence of possible opiate-induced side-effects and the difficulties with symptom control expressed by some GPs indicate a continuing need for effective educational input.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683506      PMCID: PMC1295662          DOI: 10.1177/014107689608900206

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  9 in total

1.  Terminal care at home: perspective from general practice.

Authors:  A Haines; A Booroff
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

2.  An audit of morphine prescribing in a specialist cancer hospital.

Authors:  R Turner; J Clark; T Root; L McElligott; J Hardy
Journal:  Palliat Med       Date:  1994       Impact factor: 4.762

3.  General practitioners and palliative care.

Authors:  M A Wakefield; J Beilby; M A Ashby
Journal:  Palliat Med       Date:  1993       Impact factor: 4.762

4.  Terminal care in a semi-rural area.

Authors:  E B Herd
Journal:  Br J Gen Pract       Date:  1990-06       Impact factor: 5.386

5.  Changes in prescribing for terminal care patients in general practice, hospital and hospice over a five-year period.

Authors:  W D Rees
Journal:  J R Coll Gen Pract       Date:  1987-11

6.  Dying now.

Authors:  E Wilkes
Journal:  Lancet       Date:  1984-04-28       Impact factor: 79.321

7.  At the crossroads: which direction for the hospices?

Authors:  D Clark
Journal:  Palliat Med       Date:  1994       Impact factor: 4.762

8.  Appropriate place of death for cancer patients: views of general practitioners and hospital doctors.

Authors:  D A Seamark; C P Thorne; C Lawrence; D J Gray
Journal:  Br J Gen Pract       Date:  1995-07       Impact factor: 5.386

9.  Characteristics of clients referred to home, hospice and hospital palliative care services in Western Australia.

Authors:  P J Bradshaw
Journal:  Palliat Med       Date:  1993       Impact factor: 4.762

  9 in total
  3 in total

1.  Primary care group commissioning of services: the differing priorities of general practitioners and district nurses for palliative care services.

Authors:  S Barclay; C Todd; J McCabe; T Hunt
Journal:  Br J Gen Pract       Date:  1999-03       Impact factor: 5.386

2.  How common is medical training in palliative care? A postal survey of general practitioners.

Authors:  S Barclay; C Todd; G Grande; J Lipscombe
Journal:  Br J Gen Pract       Date:  1997-12       Impact factor: 5.386

3.  Opioid analgesic prescribing and use - an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital.

Authors:  L M Nissen; S E Tett; T Cramond; B Williams; M T Smith
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.